Nitroblue tetrazolium test in patients with breast cancer undergoing mastectomy and radiotherapy.
The reduction of nitrotetrazolium blue with stimulated and unstimulated granulocytes was performed in 40 patients with breast cancer. Blood was collected from peripheral vein before surgical intervention, during surgery from vein draining of tumor, two weeks after surgery and three months after surgery when radiotherapy was finished. In parallel experiments the NBT test was made in the peripheral blood of 20 healthy individuals. We have observed decreased reduction of nitrotetrazolium blue in stimulated granulocytes, which may indicate that granulocytes from these patients are unable for efficient stimulation. No evident effect concerning the advancement of disease and applied therapy could be found. The importance of determining the NBT test in cancer patients is briefly discussed.
Merkiel
K
K
Prokopowicz
J
J
Korenkiewicz
A
A
Kiluk
S
S
D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000097:blood / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D006098:Granulocytes / Q000502:physiology; D006801:Humans; D008408:Mastectomy; D009367:Neoplasm Staging; D009580:Nitroblue Tetrazolium; D013778:Tetrazolium Salts
D013778:Tetrazolium Salts; D009580:Nitroblue Tetrazolium